Related Experiment Video
Updated: Aug 13, 2026
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Practitioner review: use of antiepileptic drugs in children
Renzo Guerrini1, Lucio Parmeggiani
1Division of Child Neurology and Psychiatry, University of Pisa & IRCCS Fondazione Stella Maris, via dei Giacinti 2, 56018 Calambrone, Pisa, Italy. renzo.guerrini@inpe.unipi.it
Insights
Accurate diagnosis is key for effective epilepsy treatment in children. Antiepileptic drugs (AEDs) control seizures in most, but research continues to refine understanding of their mechanisms and improve outcomes.
Area of Science:
- Pediatric Neurology
- Epileptology
Background:
- Epilepsy treatment aims to control seizures while preserving cognitive function and quality of life.
- Accurate seizure type recognition and epilepsy syndrome diagnosis are foundational for optimal management.
Purpose of the Study:
- To review the diagnosis and treatment of childhood epilepsy.
- To discuss key management issues including treatment initiation, failure, and target setting.
- To explore the concept of epileptic encephalopathy and the impact of interictal EEG abnormalities.
Main Methods:
- Comprehensive review of existing literature.
- Incorporation of personal clinical experience in treating pediatric epilepsy.
Main Results:
- Summarizes general aspects of childhood epilepsy diagnosis and treatment.
- Details management strategies for seizure disorders, including treatment escalation and goal setting.
- Addresses specific epilepsy syndromes like infantile spasms, focal epilepsies, absence seizures, myoclonic epilepsies, and Lennox-Gastaut syndrome.
- Discusses epileptic encephalopathy and the influence of EEG abnormalities on child development.
Conclusions:
- Antiepileptic drugs (AEDs) are effective in controlling seizures for the majority of children.
- The specificity of AEDs is currently limited, highlighting the need for ongoing research.
- Continued research is advancing the understanding of epilepsy pathogenesis and drug action mechanisms.
Background:
The aim in treating epilepsy is to minimise or control seizures with full respect of quality-of-life issues, especially of cognitive functions. Optimal treatment first demands a correct recognition of the major type of seizures, followed by a correct diagnosis of the type of epilepsy or of the specific syndrome.
Methods:
Review of data from literature and personal clinical experience in treating children with epilepsy.
Results:
After summarising the general aspects on the diagnosis and treatment of the main forms of childhood epilepsy, we review key issues about management of seizure disorders, including when to start treatment, how to proceed when the first treatment fails, and how to set the targets of treatment. A special section is devoted to the new concept of epileptic encephalopathy and to the influence of "interictal" EEG abnormalities on cognition, behaviour, and motor abilities in children, providing some suggestions on why and how to treat these conditions. A second section approaches the choice of treatment according to the specific syndromes including infantile spasms, focal epilepsies, syndromes with typical absence seizures, the myoclonic epilepsies and the Lennox-Gastaut syndrome.
Conclusions:
Antiepileptic drugs (AEDs) can efficiently control seizures in most children. However, the specificity of AEDs is relatively limited, although continuing research is leading to a better understanding of the relationship between pathogenesis and the mechanism(s) and site(s) of drug action.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...